◆ NeutralTENX
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX
GlobeNewswire Inc.·
Rosen Law Firm is reminding investors who purchased Tenax Therapeutics securities between November 13, 2023 and August 7, 2026 to join a securities class action lawsuit before the December 28, 2026 lead plaintiff deadline. The lawsuit alleges that Tenax made materially false and misleading statements about TNX-103's effectiveness and commercial prospects, causing investor damages when the true details emerged.
Read Full Article at GlobeNewswire Inc. →